Related Experiment Video
Updated: May 4, 2026

08:37
Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
2.0K
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs
Livia Garzetti1, Ramesh Menon1, Annamaria Finardi1
1Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milano, Italy.
Journal of Leukocyte Biology
|January 1, 2014
Summary
Extracellular vesicles (EVs) from myeloid cells in cerebrospinal fluid (CSF) can indicate macrophage activation. Analyzing mRNA within these EVs reveals specific activation states, aiding disease stratification.
Area of Science:
- Cell Biology
- Immunology
- Biomarkers
Background:
- Extracellular vesicles (EVs) facilitate intercellular communication and are investigated as biomarkers.
- Myeloid-derived EVs in cerebrospinal fluid (CSF) are linked to microglia/macrophage activation.
- Understanding myeloid cell activation states is crucial for disease pathogenesis.
Purpose of the Study:
- To investigate if macrophage-derived EVs reflect distinct activation states.
- To determine if mRNA cargo in EVs accurately represents the parent cell's activation phenotype.
- To establish EVs as potential tools for stratifying pathological processes.
Main Methods:
- In vitro activation of macrophages using different stimuli.
- Quantification of EVs released by activated vs. non-stimulated (NS) cells.
- mRNA profiling of EVs and parental cells to identify cargo and enrichment patterns.
Main Results:
- Activated macrophages release significantly more EVs than NS cells.
- Macrophage-derived EVs contain a non-random, enriched repertoire of specific mRNAs.
- EV mRNA content successfully identified the in vivo activation phenotype of the originating myeloid cell.
Conclusions:
- Macrophage-derived EVs carry functional traits from their parent cells.
- Detection of mRNA in myeloid EVs can identify myeloid cell activation types.
- This approach allows for improved stratification of diseases involving myeloid cell activation.

